BioNexus Gene Lab Corp.

NasdaqCM:BGLC Stock Report

Market Cap: US$5.2m

BioNexus Gene Lab Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Lee Tan

Chief executive officer

US$16.0k

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

BioNexus Gene Lab Corp. (NASDAQ:BGLC) Stocks Shoot Up 234% But Its P/S Still Looks Reasonable

Feb 14
BioNexus Gene Lab Corp. (NASDAQ:BGLC) Stocks Shoot Up 234% But Its P/S Still Looks Reasonable

CEO

Lee Tan (41 yo)

less than a year

Tenure

US$16,000

Compensation

Mr. Su-Leng Tan, also known as Lee, is CEO & Director of BioNexus Gene Lab Corp. from December 11, 2023 and also serves as its Acting Chief Financial Officer and Secretary. Mr. Tan was Chief Operating Offi...


Board Members

NamePositionTenureCompensationOwnership
Su-Leng Tan
CEO, Acting CFOless than a yearUS$16.00kno data
Chee Yap
Independent Non-Executive Director2.7yrsUS$3.00kno data
Muhammad bin Abdul Hamid
Independent Directorless than a yearno datano data

0.9yrs

Average Tenure

48yo

Average Age

Experienced Board: BGLC's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.